Koers Urovant Sciences Ltd.
Aandelen
UROV
BMG9381B1081
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James Robinson
CEO | Chief Executive Officer | 54 | 01-03-19 |
Ajay Bansal
DFI | Director of Finance/CFO | 62 | 28-10-19 |
Chief Tech/Sci/R&D Officer | 66 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Hindman
BRD | Director/Board Member | 63 | 20-05-20 |
Sef P. Kurstjens
BRD | Director/Board Member | 60 | 01-07-18 |
James Robinson
CEO | Chief Executive Officer | 54 | 01-03-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,97% | 104 mld. | |
+1,71% | 97,42 mld. | |
+0,79% | 22,2 mld. | |
-17,82% | 21,23 mld. | |
-11,11% | 18,33 mld. | |
-42,83% | 16,35 mld. | |
-17,11% | 15,06 mld. | |
+3,73% | 13,98 mld. | |
+33,26% | 11,66 mld. |